Your browser doesn't support javascript.
loading
Impact of CYP3A5 genotype on tolvaptan pharmacokinetics and their relationships with endogenous markers of CYP3A activity and serum sodium level in heart failure patients.
Hoshikawa, Kohei; Naito, Takafumi; Akutsu, Shunta; Saotome, Masao; Maekawa, Yuichiro; Kawakami, Junichi.
Afiliación
  • Hoshikawa K; Department of Hospital Pharmacy, Hamamatsu University School of Medicine, Hamamatsu, Japan.
  • Naito T; Department of Hospital Pharmacy, Hamamatsu University School of Medicine, Hamamatsu, Japan.
  • Akutsu S; Department of Hospital Pharmacy, Hamamatsu University School of Medicine, Hamamatsu, Japan.
  • Saotome M; Third Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan.
  • Maekawa Y; Third Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan.
  • Kawakami J; Department of Hospital Pharmacy, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Basic Clin Pharmacol Toxicol ; 126(4): 353-363, 2020 Apr.
Article en En | MEDLINE | ID: mdl-31652395

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Citocromo P-450 CYP3A / Tolvaptán / Insuficiencia Cardíaca Tipo de estudio: Observational_studies Límite: Aged / Aged80 / Female / Humans / Male Idioma: En Revista: Basic Clin Pharmacol Toxicol Asunto de la revista: FARMACOLOGIA / TOXICOLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Citocromo P-450 CYP3A / Tolvaptán / Insuficiencia Cardíaca Tipo de estudio: Observational_studies Límite: Aged / Aged80 / Female / Humans / Male Idioma: En Revista: Basic Clin Pharmacol Toxicol Asunto de la revista: FARMACOLOGIA / TOXICOLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Japón
...